153 related articles for article (PubMed ID: 36424660)
21. Germline breast cancer susceptibility gene mutations and breast cancer outcomes.
Wang YA; Jian JW; Hung CF; Peng HP; Yang CF; Cheng HS; Yang AS
BMC Cancer; 2018 Mar; 18(1):315. PubMed ID: 29566657
[TBL] [Abstract][Full Text] [Related]
22. The Identification by Exome Sequencing of Candidate Genes in
BenAyed-Guerfali D; Kifagi C; BenKridis-Rejeb W; Ammous-Boukhris N; Ayedi W; Khanfir A; Daoud J; Mokdad-Gargouri R
Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 35893033
[TBL] [Abstract][Full Text] [Related]
23. Almost 2% of Spanish breast cancer families are associated to germline pathogenic mutations in the ATM gene.
Tavera-Tapia A; Pérez-Cabornero L; Macías JA; Ceballos MI; Roncador G; de la Hoya M; Barroso A; Felipe-Ponce V; Serrano-Blanch R; Hinojo C; Miramar-Gallart MD; Urioste M; Caldés T; Santillan-Garzón S; Benitez J; Osorio A
Breast Cancer Res Treat; 2017 Feb; 161(3):597-604. PubMed ID: 27913932
[TBL] [Abstract][Full Text] [Related]
24. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
[TBL] [Abstract][Full Text] [Related]
25. Exome sequencing of germline DNA from non-BRCA1/2 familial breast cancer cases selected on the basis of aCGH tumor profiling.
Hilbers FS; Meijers CM; Laros JF; van Galen M; Hoogerbrugge N; Vasen HF; Nederlof PM; Wijnen JT; van Asperen CJ; Devilee P
PLoS One; 2013; 8(1):e55734. PubMed ID: 23383274
[TBL] [Abstract][Full Text] [Related]
26. Targeted sequencing to discover germline variants in the BRCA1 and BRCA2 genes in a Russian population and their association with breast cancer risk.
Solodskikh SA; Panevina AV; Gryaznova MV; Gureev AP; Serzhantova OV; Mikhailov AA; Maslov AY; Popov VN
Mutat Res; 2019 Jan; 813():51-57. PubMed ID: 30611917
[TBL] [Abstract][Full Text] [Related]
27. Novel candidates of pathogenic variants of the BRCA1 and BRCA2 genes from a dataset of 3,552 Japanese whole genomes (3.5KJPNv2).
Tokunaga H; Iida K; Hozawa A; Ogishima S; Watanabe Y; Shigeta S; Shimada M; Yamaguchi-Kabata Y; Tadaka S; Katsuoka F; Ito S; Kumada K; Hamanaka Y; Fuse N; Kinoshita K; Yamamoto M; Yaegashi N; Yasuda J
PLoS One; 2021; 16(1):e0236907. PubMed ID: 33428613
[TBL] [Abstract][Full Text] [Related]
28.
Rofes P; Del Valle J; Torres-Esquius S; Feliubadaló L; Stradella A; Moreno-Cabrera JM; López-Doriga A; Munté E; De Cid R; Campos O; Cuesta R; Teulé Á; Grau È; Sanz J; Capellá G; Díez O; Brunet J; Balmaña J; Lázaro C
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33498765
[TBL] [Abstract][Full Text] [Related]
29. Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer.
Kiiski JI; Pelttari LM; Khan S; Freysteinsdottir ES; Reynisdottir I; Hart SN; Shimelis H; Vilske S; Kallioniemi A; Schleutker J; Leminen A; Bützow R; Blomqvist C; Barkardottir RB; Couch FJ; Aittomäki K; Nevanlinna H
Proc Natl Acad Sci U S A; 2014 Oct; 111(42):15172-7. PubMed ID: 25288723
[TBL] [Abstract][Full Text] [Related]
30. Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.
Weitzel JN; Neuhausen SL; Adamson A; Tao S; Ricker C; Maoz A; Rosenblatt M; Nehoray B; Sand S; Steele L; Unzeitig G; Feldman N; Blanco AM; Hu D; Huntsman S; Castillo D; Haiman C; Slavin T; Ziv E
Cancer; 2019 Aug; 125(16):2829-2836. PubMed ID: 31206626
[TBL] [Abstract][Full Text] [Related]
31. Clinically Significant Unclassified Variants in
Yoon KA; Park B; Lee BI; Yang MJ; Kong SY; Lee ES
Cancer Res Treat; 2017 Jul; 49(3):627-634. PubMed ID: 27658390
[TBL] [Abstract][Full Text] [Related]
32. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
[TBL] [Abstract][Full Text] [Related]
33. Identification of
Hamdi Y; Boujemaa M; Mighri N; Mejri N; Jaidane O; Ben Nasr S; Bouaziz H; Hassouna JB; Zribi A; Berrazaga Y; Rachdi H; Daoud N; El Benna H; Labidi S; Haddaoui A; Rahal K; Benna F; Boussen H; Abdelhak S; Boubaker S
Front Genet; 2021; 12():674990. PubMed ID: 34456966
[No Abstract] [Full Text] [Related]
34. Whole exome sequencing suggests much of non-BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles.
Gracia-Aznarez FJ; Fernandez V; Pita G; Peterlongo P; Dominguez O; de la Hoya M; Duran M; Osorio A; Moreno L; Gonzalez-Neira A; Rosa-Rosa JM; Sinilnikova O; Mazoyer S; Hopper J; Lazaro C; Southey M; Odefrey F; Manoukian S; Catucci I; Caldes T; Lynch HT; Hilbers FS; van Asperen CJ; Vasen HF; Goldgar D; Radice P; Devilee P; Benitez J
PLoS One; 2013; 8(2):e55681. PubMed ID: 23409019
[TBL] [Abstract][Full Text] [Related]
35. Next-generation sequencing in familial breast cancer patients from Lebanon.
Jalkh N; Chouery E; Haidar Z; Khater C; Atallah D; Ali H; Marafie MJ; Al-Mulla MR; Al-Mulla F; Megarbane A
BMC Med Genomics; 2017 Feb; 10(1):8. PubMed ID: 28202063
[TBL] [Abstract][Full Text] [Related]
36. Whole exome germline sequencing in early-onset prostate cancer patients: Genomic findings and clinical outcomes.
Siegelmann-Danieli N; Neiman V; Bareket-Samish A; Berger R; Peretz A; Alapi H; Tsur E; Patalon T; Beller D; Rimler G; Chodick G; Shohat M
Prostate; 2024 Jan; 84(1):39-46. PubMed ID: 37842866
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma.
Johansson PA; Nathan V; Bourke LM; Palmer JM; Zhang T; Symmons J; Howlie M; Patch AM; Read J; Holland EA; Schmid H; Warrier S; Glasson W; Höiom V; Wadt K; Jönsson G; Olsson H; Ingvar C; Mann G; Brown KM; Hayward NK; Pritchard AL
Melanoma Res; 2019 Oct; 29(5):483-490. PubMed ID: 31464824
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and Spectrum of
Foglietta J; Ludovini V; Bianconi F; Pistola L; Reda MS; Al-Refaie A; Tofanetti FR; Mosconi A; Minenza E; Anastasi P; Molica C; Stracci F; Roila F
Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32806537
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients.
Zhong X; Dong Z; Dong H; Li J; Peng Z; Deng L; Zhu X; Sun Y; Lu X; Shen F; Su X; Zhang L; Gu Y; Zheng H
PLoS One; 2016; 11(6):e0156789. PubMed ID: 27257965
[TBL] [Abstract][Full Text] [Related]
40. Exome sequencing study of Russian breast cancer patients suggests a predisposing role for USP39.
Kuligina ES; Sokolenko AP; Bizin IV; Romanko AA; Zagorodnev KA; Anisimova MO; Krylova DD; Anisimova EI; Mantseva MA; Varma AK; Hasan SK; Ni VI; Koloskov AV; Suspitsin EN; Venina AR; Aleksakhina SN; Sokolova TN; Milanović AM; Schürmann P; Prokofyeva DS; Bermisheva MA; Khusnutdinova EK; Bogdanova N; Dörk T; Imyanitov EN
Breast Cancer Res Treat; 2020 Feb; 179(3):731-742. PubMed ID: 31754952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
